Chemical Structure (Chlordiazepoxide 01)
Chlordiazepoxide Hydrochloride And Clidinium Bromide
Product Images NDC 71186-006
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 71186-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Vilvet Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Chlordiazepoxide 02)
Principal Display Panel (100 Capsule Bottle Label)
This text mentions guidelines for administering and storing a medication containing Chlordiazepoxide HCI and Clidinium Bromide, which come in capsules and should be kept in a light-resistant container. The capsules should be taken orally as prescribed by a physician, and kept out of the reach of children. In case of accidental overdose, a doctor or poison control center should be contacted immediately. The medication should be stored at room temperature, with some leeway for temperature excursions. For more product information or to report a serious adverse event, a phone number and a website are provided. The medication is only available by prescription and is manufactured by Vilvet Pharmaceuticals Inc. in Pennsylvania.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
